Award recordCONTRACT

APO-PHARMA USA, INC.

PIID VA25513F2843· VHA· 255-NETWORK CONTRACT OFFICE 15· 6505 · DRUGS AND BIOLOGICALS· FY2013· $86,602 net obligations· UEI JDSKMX3AW5M5· MD

Description

FERRIPROX (DEFERIPRONE) 500MG (NDC: 52609-0006-01

First action · last action
2013-06-05 · 2014-03-11
Transactions
2
First transaction's obligation
$87,112
Base + all options value (sum of deltas)
$86,602
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P5203E
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$87,112$0Base award · 2013-06-05 · this action $87,112 · running total $87,112Modification P00001 · 2014-03-11 · this action -$510 · running total $86,602
  • Base2013-06-05+$87,112= $87,112
  • Mod P000012014-03-11-$510= $86,602
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2013-06-05+$87,112$87,112FERRIPROX (DEFERIPRONE) 500MG (NDC: 52609-0006-01
Mod P00001· FUNDING ONLY ACTION2014-03-11−$510$86,602FERRIPROX (DEFERIPRONE) 500MG (NDC: 52609-0006-01

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI JDSKMX3AW5M5)

AwardOffice · PSC / listingNet obligationsFY
36C24520F0484245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$50,449FY2020
36C24820F0107248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$14,407FY2020
36C24520F0248245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$53,556FY2020
36C24220F0122242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$17,852FY2020
36C24519F0803245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$44,630FY2019
36C24219F0433242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$0FY2019

Other recipients under 6505 from 255-NETWORK CONTRACT OFFICE 15 (most recent first)

AwardRecipientOfficeNet obligationsFY
VA25516F2420CSL BEHRING L.L.C.255-NETWORK CONTRACT OFFICE 15$5,811FY2016
VA25516F2412BAYER HEALTHCARE PHARMACEUTICALS INC255-NETWORK CONTRACT OFFICE 15$51,581FY2016
VA25516P2404MCKESSON PLASMA AND BIOLOGICS LLC255-NETWORK CONTRACT OFFICE 15$10,851FY2016
VA25516J2221RED RIVER PHARMACY OF JONESBORO, LLC255-NETWORK CONTRACT OFFICE 15$187,797FY2016
VA25516D0093RED RIVER PHARMACY OF JONESBORO, LLC255-NETWORK CONTRACT OFFICE 15$0FY2016

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25513F2843_3600_V797P5203E_3600 · retrieved 2026-09-26.